This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.


June 13, 2024
This paper reports the interim findings from the clinical registry that was initiated after FDA approval to validate the findings of the 386 PROACT trial for the On-X aortic valve. The original trial showed that low dose warfarin (INR range 1.5-2.0) and aspirin were safe starting at least three months after On-X aortic valve implantation.
June 13, 2024
The COMICS trial is the largest randomized trial of minimally invasive extracorporeal circulation (MiECC) compared to conventional ECC (CECC). MiECC reduced the frequency of SAEs prespecified to qualify for the primary outcome.
June 13, 2024
This video describes the authors’ technique for harvesting valved aortic and pulmonary homografts that are needed for various surgical cardiac reconstructions. from human cadaveric hearts.
June 12, 2024
In this short video, Dr. Andrew Owens talks through and gives a few good tips for a safe redo sternotomy.
June 11, 2024
This video presents a case of minimally invasive mitral valve replacement, left atrial appendage closure, and left atrium plication.
June 7, 2024
Prof. Tristan Yan details the history of aortic surgery. Stay tuned for more videos from Prof. Yan on essential aortic procedures.
June 7, 2024
This week on The Beat, Editor in Chief Joel Dunning interviews Prof. Dawn Jaroszewski. They discuss the latest techniques in pectus excavatum surgery and Prof. Jaroszewski’s recommendations for safe pectus guidelines. She goes on to demonstrate some of her techniques on a chest cavity simulator.
June 7, 2024
ERAS Cardiac Society once more conducted a joint webinar with CTSNet on May 30, 2024, bringing about presentations, discussion, and questions on, "Chest Tube Management in Cardiac Surgery." The session included presentations from Dr. Marc Gillinov, Dr. Jurij Kalisnik, and Dr. Lenard Conradi, with Dr. Kevin Lobdell and Dr.
June 5, 2024
In an analysis of 1,826 patients randomized to surgical aortic valve replacement in the three Placement of Aortic Transcatheter Valves (PARTNER) trials, patient-prosthesis mismatch was assessed using transthoracic echocardiography and by the normal reference value for each size and model of implanted valve.